KYOWA KIRIN CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1949-07-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- http://www.kyowa-kirin.co.jp
Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15
Phase 2
Completed
- Conditions
- Adult T-cell Leukemia-Lymphoma
- Interventions
- Drug: VCAP/AMP/VECP(mLSG15)Biological: KW-0761
- First Posted Date
- 2010-08-02
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 44
- Registration Number
- NCT01173887
- Locations
- 🇯🇵
Imamura Bun-in Hospital, Kagoshima, Japan
🇯🇵Kagoshima University Hospital, Kagoshima, Japan
🇯🇵Kokura Memorial Hospital, Kitakyushu, Japan
A Clinical Pharmacology Study of Saxagliptin in Patients With Type 2 Diabetes Mellitus
Phase 3
Completed
- Conditions
- Diabetes
- Interventions
- Drug: saxaglipitin
- First Posted Date
- 2010-07-15
- Last Posted Date
- 2017-03-09
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT01162876
- Locations
- 🇯🇵
Kyushu Clinical Pharmacology Reserch Clinic, Fukuoka, Japan
Study of ARQ 197 Monotherapy
- First Posted Date
- 2010-06-29
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 31
- Registration Number
- NCT01152645
Effect of External Heat on a Transdermal Granisetron Patch in Pharmacokinetics (PK) of Healthy Subjects
- First Posted Date
- 2010-02-23
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT01073696
- Locations
- 🇬🇧
Quotient Clinical Limited, Edinburgh, United Kingdom
A Study of ARQ 197 in Combination With Erlotinib
- First Posted Date
- 2010-02-17
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT01069757
A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 95
- Registration Number
- NCT01063907
- Locations
- 🇺🇸
Arizona Clinical Research Center, Inc. / Arizona Oncology Associates, 1825 N Kolb,, Tucson, Arizona, United States
🇺🇸Pacific Shores Medical Group 1043 Elm Ave, Suite 104, Long Beach, California, United States
🇺🇸Collaborative Research Group 2320 S Seacrest Blvd, Suite 202, Boynton Beach, Florida, United States
Extended Long-Term Safety Study of KW-6500
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 27
- Registration Number
- NCT01063621
Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500
- First Posted Date
- 2010-01-28
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 31
- Registration Number
- NCT01058291
- Locations
- 🇯🇵
Ehime University Hospital, Toon, Ehime, Japan
A Study of OPC-262 in Patients With Type 2 Diabetes
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2014-01-08
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT01046318
A Study of OPC-262 in Patients With Type 2 Diabetes
Phase 2
Completed
- Conditions
- Diabetes Type 2
- Interventions
- Drug: OPC-262 2.5 mgDrug: OPC-262 5 mgDrug: Placebo
- First Posted Date
- 2009-10-19
- Last Posted Date
- 2014-01-08
- Lead Sponsor
- Kyowa Kirin Co., Ltd.
- Target Recruit Count
- 255
- Registration Number
- NCT00997282
© Copyright 2025. All Rights Reserved by MedPath